Real-world characteristics and outcomes of patients with BRAFV600E-mutant metastatic colorectal cancer in Australia: the COALA project
Nadia Hitchen(Peter MacCallum Cancer Centre), J. Tie(Walter and Eliza Hall Institute of Medical Research), J. Torres(Goulburn Valley Health), Hui‐Li Wong(Walter and Eliza Hall Institute of Medical Research), Hiren Mandaliya(Lake Macquarie Private Hospital), Vanessa Wong(Walter and Eliza Hall Institute of Medical Research), B. Lee(Northern Health), F. Susan Wong(University Hospitals Birmingham NHS Foundation Trust), Theresa Hayes(St John of God Hospital), Azim Jalali(Walter and Eliza Hall Institute of Medical Research), Peter Gibbs(The University of Melbourne), Susan Caird(Gold Coast Hospital), Stephanie Lim(Camden and Campbelltown Hospitals), Natalie Rainey(Queensland Government), L. Nott(Royal Hobart Hospital), Rachel Wong(Box Hill Hospital), Adnan Khattak(Edith Cowan University), J. Shapiro(Cabrini Hospital), M. Burge(Royal Brisbane and Women's Hospital), A. Campbell(Walter and Eliza Hall Institute of Medical Research)
Cited by 1
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Detection and localization of surgically resectable cancers with a multi-analyte blood test
|Science|2018|2.8k
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
|New England Journal of Medicine|2018|1.9k
Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer
|Science Translational Medicine|2016|1.5k